Jeet Mukherjee
Stock Analyst at BTIG
(4.74)
# 649
Out of 4,604 analysts
132
Total ratings
62.6%
Success rate
28.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PVLA Palvella Therapeutics | Maintained: Buy | $215 | $151.99 | +41.46% | 10 | Aug 4, 2026 | |
| IBRX ImmunityBio | Maintained: Buy | $12 | $6.95 | +72.66% | 7 | Aug 4, 2026 | |
| BCAX Bicara Therapeutics | Maintained: Buy | $28 | $26.10 | +7.28% | 6 | Jul 27, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $117 | $118.46 | -1.23% | 16 | Jul 22, 2026 | |
| FTH Faeth Therapeutics | Maintained: Buy | $55 | $25.50 | +115.69% | 4 | Jul 15, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $42 | $31.49 | +33.38% | 3 | Jul 14, 2026 | |
| NRIX Nurix Therapeutics | Rated: Buy | $32 | $24.69 | +29.61% | 12 | Jul 1, 2026 | |
| KYMR Kymera Therapeutics | Maintained: Buy | $138 → $134 | $104.39 | +28.36% | 13 | Jun 25, 2026 | |
| VSTM Verastem | Reiterated: Buy | $18 | $5.81 | +209.81% | 5 | Jun 24, 2026 | |
| AARD Aardvark Therapeutics | Downgraded: Hold | n/a | $7.23 | - | 9 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $9.00 | +100.00% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.79 | +348.18% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $16.69 | +187.60% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.00 | +366.67% | 9 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $32.94 | +279.48% | 5 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $4.86 | +126.34% | 4 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.47 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $91 | $19.13 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $0.7365 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $61.11 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $15.96 | n/a | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.35 | n/a | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $36.11 | n/a | 1 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0025 | n/a | 1 | Apr 1, 2025 |
Palvella Therapeutics
Aug 4, 2026
Maintained: Buy
Price Target: $215
Current: $151.99
Upside: +41.46%
ImmunityBio
Aug 4, 2026
Maintained: Buy
Price Target: $12
Current: $6.95
Upside: +72.66%
Bicara Therapeutics
Jul 27, 2026
Maintained: Buy
Price Target: $28
Current: $26.10
Upside: +7.28%
Monopar Therapeutics
Jul 22, 2026
Maintained: Buy
Price Target: $117
Current: $118.46
Upside: -1.23%
Faeth Therapeutics
Jul 15, 2026
Maintained: Buy
Price Target: $55
Current: $25.50
Upside: +115.69%
ArriVent BioPharma
Jul 14, 2026
Maintained: Buy
Price Target: $42
Current: $31.49
Upside: +33.38%
Nurix Therapeutics
Jul 1, 2026
Rated: Buy
Price Target: $32
Current: $24.69
Upside: +29.61%
Kymera Therapeutics
Jun 25, 2026
Maintained: Buy
Price Target: $138 → $134
Current: $104.39
Upside: +28.36%
Verastem
Jun 24, 2026
Reiterated: Buy
Price Target: $18
Current: $5.81
Upside: +209.81%
Aardvark Therapeutics
May 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.23
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $9.00
Upside: +100.00%
May 13, 2026
Maintained: Buy
Price Target: $8
Current: $1.79
Upside: +348.18%
May 13, 2026
Maintained: Buy
Price Target: $48
Current: $16.69
Upside: +187.60%
May 12, 2026
Reiterated: Buy
Price Target: $14
Current: $3.00
Upside: +366.67%
May 1, 2026
Reiterated: Buy
Price Target: $125
Current: $32.94
Upside: +279.48%
Mar 11, 2026
Maintained: Buy
Price Target: $11
Current: $4.86
Upside: +126.34%
May 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.47
Upside: n/a
May 23, 2025
Maintained: Buy
Price Target: $91
Current: $19.13
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: $12
Current: $0.7365
Upside: n/a
May 13, 2025
Initiated Coverage: Buy
Price Target: $42
Current: $61.11
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $100
Current: $15.96
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $10
Current: $3.35
Upside: n/a
Apr 14, 2025
Maintained: Buy
Price Target: $62
Current: $36.11
Upside: n/a
Apr 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0025
Upside: n/a